Pirenoxine (International)
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0001043-21-6
Chemical Formula
C16-H8-N2-O5
Molecular Weight
308
Therapeutic Category
Cataract treatment
Chemical Name
5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-
Foreign Names
- Pirenoxinum (Latin)
- Pirenoxin (German)
- Pirénoxine (French)
- Pirenoxina (Spanish)
Generic Names
- Pirenoxine (OS: JAN)
- Pirénoxine (OS: DCF)
- Pirfenoxone (IS)
- Pirenoxine (PH: JP XVII)
Brand Names
- Catalin
Senju, China; Takeda, Egypt - Catalin 0.005%
Senju Seiyaku, Japan - Catalin K 0.005%
Senju Seiyaku, Japan - Clarvisan
Allergan, Italy; Lusomedicamenta, Portugal - Kary Uni
Ferron/Santen, Indonesia; Santen, Philippines; Santen, Thailand; Santen, Taiwan; Santen Pharmaceutical Asia, Singapore; Santen Pharmaceutical China, China - Kary Uni 0.005%
Santen Pharmaceutical, Japan - Pirenoxine 0.005%
Nitto Medic, Japan - Pirenoxine Nitto Medic
Nitto, Taiwan - Catalin
Allergan, India; Helix, Pakistan; PharmaHeads, Poland; Takeda, Hong Kong - Catalin [+ Taurine]
Takeda, Kuwait - Clarvisol
Allergan, Brazil - Kary Uni
Santen, Hong Kong - Pirenoxine Sodium - KeRui Pharm
Kerui Pharmaceutical, China - Pirfalin
Farmigea, Italy; Farmigea, Malta
Glossary
Term | Definition |
---|---|
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.